Monoferric
Active Ingredient(s): Ferric DerisomaltoseFDA Approved: * January 16, 2020
Pharm Company: * PHARMACOSMOS AS
Category: Anemia
Ferric derisomaltose, sold under the brand name Monoferric, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD).[1] It was approved for use in the United States in January 2020.[1][2][3] It is given intravenously.[1] References .mw-par... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.